Role of the MAP Kinase Pathway in NSCLC
Bruce E. Johnson, MD; Mark A. Socinski, MD; and Roy S. Herbst, MD, PhD, describe the role of the MAP kinase pathway and the synergism of BRAF/MEK inhibitors in non–small cell lung cancer.
Bruce E. Johnson, MD; Mark A. Socinski, MD; and Roy S. Herbst, MD, PhD, describe the role of the MAP kinase pathway and the synergism of BRAF/MEK inhibitors in non–small cell lung cancer.
